Literature DB >> 10331651

Function of poly(ADP-ribose) polymerase in response to DNA damage: gene-disruption study in mice.

M Masutani1, T Nozaki, E Nishiyama, T Shimokawa, Y Tachi, H Suzuki, H Nakagama, K Wakabayashi, T Sugimura.   

Abstract

To elucidate the biological functions of poly(ADP-ribose) polymerase (PARP, [EC 2.4.2.30]) in DNA damage responses, genetic and biochemical approaches were undertaken. By disrupting exon 1 of the mouse PARP gene by a homologous recombination, PARP-deficient mouse embryonic stem (ES) cell lines and mice could be produced without demonstrating lethality. PARP-/- ES cells showed complete loss of PARP activity and increased sensitivity to gamma-irradiation and an alkylating agents, indicating a physiological role for PARP in the response to DNA damage. p53, a key molecule in cellular DNA damage response, was found to stimulate PARP activity and became poly(ADP-ribosyl)ated in the presence of damaged DNA. However, PARP-/- ES cells showed p21 and Mdm-2 mRNA induction following gamma-irradiation, indicating that PARP activity is not indispensable for p21 and Mdm-2 mRNA induction in the established p53-cascade. On the other hand, in a reconstituted reaction system, purified PARP from human placenta suppressed the pRB-phosphorylation activity in the presence of NAD and damaged DNA. Human PARP expressed in E. coli showed a similar effect on pRB-phosphorylation activity of cdk2. These findings suggest a direct involvement of PARP in the regulation of cdk activity for cell-cycle arrest.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10331651

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  16 in total

Review 1.  Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells.

Authors:  L Hartwell
Journal:  Cell       Date:  1992-11-13       Impact factor: 41.582

2.  ADP-ribosylation of wild-type p53 in vitro: binding of p53 protein to specific p53 consensus sequence prevents its modification.

Authors:  J Wesierska-Gadek; G Schmid; C Cerni
Journal:  Biochem Biophys Res Commun       Date:  1996-07-05       Impact factor: 3.575

3.  Cell cycle perturbations following DNA damage in the presence of ADP-ribosylation inhibitors.

Authors:  E L Jacobson; R Meadows; J Measel
Journal:  Carcinogenesis       Date:  1985-05       Impact factor: 4.944

Review 4.  Poly(adenosine diphosphate ribose).

Authors:  T Sugimura
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  1973

5.  Stable production of mutant mice from double gene converted ES cells with puromycin and neomycin.

Authors:  S Watanabe; N Kai; M Yasuda; N Kohmura; M Sanbo; M Mishina; T Yagi
Journal:  Biochem Biophys Res Commun       Date:  1995-08-04       Impact factor: 3.575

6.  A dominant-negative mutant of human poly(ADP-ribose) polymerase affects cell recovery, apoptosis, and sister chromatid exchange following DNA damage.

Authors:  V Schreiber; D Hunting; C Trucco; B Gowans; D Grunwald; G De Murcia; J M De Murcia
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-23       Impact factor: 11.205

7.  Mice lacking ADPRT and poly(ADP-ribosyl)ation develop normally but are susceptible to skin disease.

Authors:  Z Q Wang; B Auer; L Stingl; H Berghammer; D Haidacher; M Schweiger; E F Wagner
Journal:  Genes Dev       Date:  1995-03-01       Impact factor: 11.361

Review 8.  Role of poly(ADP-ribose) polymerase in cell-cycle checkpoint mechanisms following gamma-irradiation.

Authors:  M Masutani; T Nozaki; K Wakabayashi; T Sugimura
Journal:  Biochimie       Date:  1995       Impact factor: 4.079

9.  Inactivation of the poly(ADP-ribose) polymerase gene affects oxygen radical and nitric oxide toxicity in islet cells.

Authors:  B Heller; Z Q Wang; E F Wagner; J Radons; A Bürkle; K Fehsel; V Burkart; H Kolb
Journal:  J Biol Chem       Date:  1995-05-12       Impact factor: 5.157

10.  Suppression of G1 arrest and enhancement of G2 arrest by inhibitors of poly(ADP-ribose) polymerase: possible involvement of poly(ADP-ribosyl)ation in cell cycle arrest following gamma-irradiation.

Authors:  T Nozaki; M Masutani; T Akagawa; T Sugimura; H Esumi
Journal:  Jpn J Cancer Res       Date:  1994-11
View more
  32 in total

Review 1.  Manipulating the mammalian genome by homologous recombination.

Authors:  K M Vasquez; K Marburger; Z Intody; J H Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-17       Impact factor: 11.205

2.  Base excision repair is efficient in cells lacking poly(ADP-ribose) polymerase 1.

Authors:  M D Vodenicharov; F R Sallmann; M S Satoh; G G Poirier
Journal:  Nucleic Acids Res       Date:  2000-10-15       Impact factor: 16.971

Review 3.  PARP inhibition: PARP1 and beyond.

Authors:  Michèle Rouleau; Anand Patel; Michael J Hendzel; Scott H Kaufmann; Guy G Poirier
Journal:  Nat Rev Cancer       Date:  2010-03-04       Impact factor: 60.716

4.  Syncytiotrophoblastic giant cells in teratocarcinoma-like tumors derived from Parp-disrupted mouse embryonic stem cells.

Authors:  T Nozaki; M Masutani; M Watanabe; T Ochiya; F Hasegawa; H Nakagama; H Suzuki; T Sugimura
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

5.  Poly(ADP-ribose) polymerase gene disruption conferred mice resistant to streptozotocin-induced diabetes.

Authors:  M Masutani; H Suzuki; N Kamada; M Watanabe; O Ueda; T Nozaki; K Jishage; T Watanabe; T Sugimoto; H Nakagama; T Ochiya; T Sugimura
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

6.  Cells deficient in PARP-1 show an accelerated accumulation of DNA single strand breaks, but not AP sites, over the PARP-1-proficient cells exposed to MMS.

Authors:  Brian F Pachkowski; Keizo Tano; Valeriy Afonin; Rhoderick H Elder; Shunichi Takeda; Masami Watanabe; James A Swenberg; Jun Nakamura
Journal:  Mutat Res       Date:  2009-09-22       Impact factor: 2.433

Review 7.  Targeting poly(ADP-ribose) polymerase activity for cancer therapy.

Authors:  Frédérique Mégnin-Chanet; Marc A Bollet; Janet Hall
Journal:  Cell Mol Life Sci       Date:  2010-08-20       Impact factor: 9.261

Review 8.  Therapeutic applications of PARP inhibitors: anticancer therapy and beyond.

Authors:  Nicola J Curtin; Csaba Szabo
Journal:  Mol Aspects Med       Date:  2013-01-29

9.  Parp-1 protects homologous recombination from interference by Ku and Ligase IV in vertebrate cells.

Authors:  Helfrid Hochegger; Donniphat Dejsuphong; Toru Fukushima; Ciaran Morrison; Eiichiro Sonoda; Valérie Schreiber; Guang Yu Zhao; Alihossein Saberi; Mitsuko Masutani; Noritaka Adachi; Hideki Koyama; Gilbert de Murcia; Shunichi Takeda
Journal:  EMBO J       Date:  2006-02-23       Impact factor: 11.598

10.  Transcription regulation of TNF-alpha-early response genes by poly(ADP-ribose) polymerase-1 in murine heart endothelial cells.

Authors:  Ana Carrillo; Yolanda Monreal; Pablo Ramírez; Luis Marin; Pascual Parrilla; Francisco Javier Oliver; José Yélamos
Journal:  Nucleic Acids Res       Date:  2004-02-03       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.